TRex Bio
Kelly Snyder is an experienced clinical operations professional currently serving as Associate Director at TRexBio since September 2025. Prior to this role, Kelly held various positions at BeiGene from September 2017 to September 2025, including Senior Clinical Study Manager, where responsibilities included study delivery, team leadership, and development of operational tools. Kelly also has extensive experience in managing clinical trials, having worked as Clinical Study Manager and Associate Clinical Study Manager at BeiGene, as well as in roles at Pfizer and other organizations. Kelly's educational background includes an Extended Education Postbaccalaureate Program in Clinical Trials Design and Management at San Francisco State University and a degree from Southern Methodist University.
This person is not in any teams
This person is not in any offices
TRex Bio
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases.